±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨ : ±¹°¡º° Áúȯ À¯º´·ü µ¥ÀÌÅÍ(2024³â)
2024 Refractive Error Disease Model: Country-Level Disease Prevalence Data
»óǰÄÚµå : 1660109
¸®¼­Ä¡»ç : Market Scope, LLC
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 9,250 £Ü 13,019,000
PDF Only (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 13,850 £Ü 19,493,000
PDF & Excel (Enterprise License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF & Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨(2024³â)Àº Àα¸ 100¸¸¸í ÀÌ»óÀÇ ¸ðµç ±¹°¡¿¡ ´ëÇØ ¿¬·ÉÃþº° 5°³ÀÇ ±¼Àý ÀÌ»ó ¹üÁÖ¿¡ ´ëÇÑ ±¹°¡ ¼öÁØÀÇ ±¤¹üÀ§ÇÑ À¯º´·ü µ¥ÀÌÅÍ¿Í 5³â°£ ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ µ¶Æ¯ÇÑ ¸ðµ¨Àº ¼¼°èÀÇ ÃֽŠÀÓ»ó ¿¬±¸¿Í Àα¸ ¿ªÇÐ ¿¹ÃøÀ» °í·ÁÇÏ¿© °í°´ÀÇ ´Ù¾çÇÑ ¿ä±¸¿¡ ¸Â°Ô Áö¿ª ¹× Áúº´ ¹üÁÖº°·Î ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Áúº´ ¸ðµ¨Àº ÀÓ»ó ¹× »ó¾÷ ´Ü°è¿¡¼­ Á¦Ç°ÀÇ Å¸°Ù ½ÃÀåÀ» Æò°¡Çϰí Áúº´ Àα¸ÀÇ ¾ç°ú Àα¸ Åë°è¿¡ ´ëÇÑ ÅëÂû·ÂÀ» ¾ò´Â µ¥ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

³»¿ë

2024³â ±¼Àý ÀÌ»ó Áúȯ ¸ðµ¨'Àº Àα¸ 100¸¸¸í ÀÌ»óÀÇ 228 °³±¹ÀÇ ´ÙÀ½ Áúº´¿¡ ´ëÇÑ ¿¬·ÉÃþº° ±¹°¡ ¼öÁØ À¯º´·ü µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù.

  • ±Ù½Ã(ÁßÁõµµº°; Àú, Áß, °í)
  • ¿ø½Ã
  • ³ë¾È
  • ³ë¾È
  • ³­½Ã
SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Market Scope's "2024 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients' diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Contents:

The "2024 Refractive Error Model" provides country-level prevalence data by age group for the 228 countries with a population over a million for the following conditions:

  • Myopia (by severity; low, moderate, high)
  • Hyperopia
  • Presbyopia
  • Plano-presbyopes
  • Astigmatism
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â